SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 28, 1995 (Earliest event reported - July 19, 1995) Commission File Number 0-8092 OXIS INTERNATIONAL, INC. A Delaware corporation I.R.S. Employer Identification No. 94-1620407 6040 N. Cutter Circle, Suite 317 Portland, OR 97217 Telephone: (503) 283-3911 FAX: (503) 283-4058 Item 7. Financial Statements and Exhibits - ------------------------------------------ (a) and (b) Financial Statements and Pro Forma Financial Information -------------------------------------------------------- On August 3, 1995, the Company filed a Report on Form 8-K reporting the acquisition of Therox Pharmaceuticals, Inc. ("Therox"). The Report on Form 8-K indicated that additional financial information would be filed under cover of a Form 8-K/A report. The additional financial information is provided herewith, as follows. . Audited financial statements of Therox as of, and for the two years ended, December 31, 1994. . Unaudited financial statements of Therox as of, and for the three months ended March 31, 1995. . Pro forma balance sheets for the two companies combined as of December 31, 1994 and March 31, 1995. . Pro forma statements of operations for the two companies for the year ended December 31, 1994 and for the three months ended March 31, 1995. (c) Exhibits -------- Exhibit 99(1) Audited financial statements of Therox as of, and for the two years ended, December 31, 1994. Exhibit 99(2) Unaudited financial statements of Therox as of, and for the three months ended March 31, 1995. Exhibit 99(3) Unaudited pro forma financial information including: . A pro forma balance sheet for the two companies combined as of December 31, 1994. . A pro forma statement of operations for the two companies combined for the year ended December 31, 1994. . A pro forma balance sheet for the two companies combined as of March 31, 1995. . A pro forma statement of operations for the two companies combined for the three months ended March 31, 1995. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. September 28, 1995 OXIS International, Inc. s/ Jon S. Pitcher ----------------------- Jon S. Pitcher Chief Financial Officer 3 EXHIBIT INDEX
Page Exhibit Number - ------- ------ 99(1) Audited financial statement of Therox as of, and for the two years ended, December 31, 1994. 5 99(2) Unaudited financial statements of Therox as of, and for the three months ended March 31, 1995. 14 99(3) Unaudited pro forma financial information including: 19 . A pro forma balance sheet for the two companies combined as of December 31, 1994. . A pro forma statement of operations for the two companies combined for the year ended December 31, 1994. . A pro forma balance sheet for the two companies combined as of March 31, 1995. . A pro forma statement of operations for the two companies combined for the three months ended March 31, 1995.
4